ACE and heart failure: Inhibitors of the Renin–Angiotensin–Aldosterone system (RAS-Inhibitors), especially Angiotensin II receptor antagonists and Angiotensin-converting enzyme (ACE) inhibitors, are popular in the non-cirrhotic normal population for the treatment of hypertension or heart failure with reduced ejection fraction6.